Chronic myelogenous leukaemia, tyrosine kinase inhibitor, interferon, deep molecular response
hematologic malignancies, sarcopenia, pre-existing sarcopenia, adipopenia, pre-existing adipopenia, intensive care unit, critical care, sepsis, septic shock